[Treatment with intravenous immunoglobulin in neurological diseases. A descriptive study of effects seen from the patient's and health services' perspectives]

MeSH terms

• Attitude of Health Personnel
• Autoimmune Diseases of the Nervous System / drug therapy
• Cost-Benefit Analysis
• Follow-Up Studies
• Humans
• Immunoglobulins, Intravenous / adverse effects
• Immunoglobulins, Intravenous / economics
• Immunoglobulins, Intravenous / therapeutic use*
• Nervous System Diseases / drug therapy*
• Patient Satisfaction
• Risk Factors
• Surveys and Questionnaires
• Treatment Outcome